Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
As of April 1, 2020, 885,689 cases of infections by the novel coronavirus SARS-CoV-2
(COVID-19) have been recorded worldwide; 44,217 of them have died (https://www …
(COVID-19) have been recorded worldwide; 44,217 of them have died (https://www …
[HTML][HTML] Role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency …
ST Rehan, H ul Hussain, E Ali, KA Kumar, S Tabassum… - Medicine, 2023 - journals.lww.com
Background: Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory
biomarker that is used to predict mortality, readmission, early discharge, and LOS, thus …
biomarker that is used to predict mortality, readmission, early discharge, and LOS, thus …
Soluble urokinase plasminogen activator receptor (suPAR) independently predicts severity and length of hospitalisation in patients with COVID-19
H Enocsson, C Idoff, A Gustafsson, M Govender… - Frontiers in …, 2021 - frontiersin.org
Background: Efficient healthcare based on prognostic variables in hospitalised patients with
COVID-19 could reduce the risk of complications and death. Recently, soluble urokinase …
COVID-19 could reduce the risk of complications and death. Recently, soluble urokinase …
Utility of P-SEP, sTREM-1 and suPAR as novel sepsis biomarkers in SARS-CoV-2 infection
S Dholariya, DN Parchwani, R Singh… - Indian Journal of Clinical …, 2022 - Springer
The coronavirus disease 2019 is a highly contagious viral infection caused by SARS-CoV-2
virus, member of coronaviridae family. It causes life threatening complications due to …
virus, member of coronaviridae family. It causes life threatening complications due to …
Prognostic role of soluble urokinase plasminogen activator receptor at the emergency department: a position paper by the Hellenic sepsis study group
In light of the accumulating evidence on the negative predictive value of soluble urokinase
plasminogen activator receptor (suPAR), a group of experts from the fields of intensive care …
plasminogen activator receptor (suPAR), a group of experts from the fields of intensive care …
Soluble urokinase plasminogen activator receptor (suPAR) in the Emergency Department (Ed): a tool for the assessment of elderly patients
RM Holstein, S Seppälä, J Kaartinen… - Journal of clinical …, 2022 - mdpi.com
Emergency department (ED) overcrowding is a global issue setting challenges to all care
providers. Elderly patients are frequent visitors of the ED and their risk stratification is …
providers. Elderly patients are frequent visitors of the ED and their risk stratification is …
Soluble urokinase plasminogen activator receptor as a decision marker for early discharge of patients with COVID-19 symptoms in the emergency department
MA Stauning, I Altintas, T Kallemose… - The Journal of …, 2021 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (The Covid-19 pandemic)
strains health care capacity. Better risk stratification, with discharge of patients with a …
strains health care capacity. Better risk stratification, with discharge of patients with a …
suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department
S Santeri, AA Peter, N Kristiina, EO Jesper… - BMC Emergency …, 2021 - Springer
Background Soluble urokinase plasminogen activator receptor (suPAR) levels have
previously been associated with readmission and mortality in acute medical patients in the …
previously been associated with readmission and mortality in acute medical patients in the …
suPAR cut-offs for risk stratification in patients with symptoms of COVID-19
I Altintas, J Eugen-Olsen, S Seppälä… - Biomarker …, 2021 - journals.sagepub.com
Objectives: Elevated soluble urokinase Plasminogen Activator Receptor (suPAR) is a
biomarker associated with adverse outcomes. We aimed to investigate the associations …
biomarker associated with adverse outcomes. We aimed to investigate the associations …
[HTML][HTML] Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
D Velissaris, N Zareifopoulos… - Caspian Journal of …, 2022 - ncbi.nlm.nih.gov
Background: The biomarker soluble urokinase plasminogen activator receptor (suPAR) is an
indicator of inflammation which is increased in a variety of chronic and acute disease states …
indicator of inflammation which is increased in a variety of chronic and acute disease states …